Article Text
Statistics from Altmetric.com
Once again, on behalf of the President, Board, Executive and Programme Committee at the British Cardiovascular Society (BCS), we look forward to welcoming you to Manchester in June for the BCS 2019 Annual Conference.
Our theme this year is ‘Digital Health Revolution’ which will give delegates the opportunity to explore how healthcare is rapidly changing in the digital era and to examine the challenges and opportunities that new technologies will place on improving patient outcomes.
The conference will be opened by the BCS President, Professor Simon Ray, followed by the keynote opening lecture entitled ‘The Cycle of Evidence Generation and Consumption in the 4th Industrial Revolution’ delivered by Dr Robert Califf (figure 1). Dr Califf is the former Commissioner of the Food and Drug Administration. He was a Professor of Medicine and Vice Chancellor for Clinical and Translational Research at Duke University. A nationally and internationally recognised expert in cardiovascular medicine, health outcomes research, healthcare quality and clinical research, Dr Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1200 publications in the peer-reviewed literature.
Theme of ‘Digital Health Revolution’
This year many of the subspecialist sessions are focused around the conference theme, which runs through the 3-day meeting. We also have the dedicated ‘something different’ sessions that will cover key topics including: Big Data, Artificial Intelligence and Machine Learning, as well as Digital Security for you and the National Health Service (NHS). Watch out for the ‘Live-Hack’—learn how secure your mobile device really is, if you dare …?
What’s new for 2019?
As usual, there is an action-packed programme that includes all the popular subspecialty tracks, the hallmark of our conference for education and revalidation. In response to feedback from …
Footnotes
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.
Patient consent for publication Not required.